Piramal Enterprises Limited Drug For Further Processing
NDC Database

Name: Piramal Enterprises Limited Drug For Further Processing NDC Database
Creator: U.S. Food and Drug Administration
License: https://www.fda.gov/
Keywords: Piramal Enterprises Limited Drug For Further Processing, NDC, National Drug Code, FDA NDC, pharmaceutical products

Piramal Enterprises Limited Drug For Further Processing

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing

Total Records 7
Latest Marketing Date 2023-05-02
Data Source FDA
First Marketing Date 2013-01-01

All

View

Bulk Ingredient

View

Drug for Further Processing

View

Company Overview

Company

Piramal Enterprises Limited Drug For Further Processing

Country

India

Website

Visit Website

contact.us@piramal.com

Social Profiles

LinkedIn X / Twitter

Company Snapshot

Piramal Enterprises Limited Drug For Further Processing

Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai 400070 Maharashtra

India

www.piramal.com/businesses/piramal-enterprises/piramal-pharma/ contact.us@piramal.com View on Map

NDC Records ( 7 records )

2022

01 Feb

Drug for Further Processing NDC: 24584-1114

Nonproprietary Name

Cloprostenol Sodium

Dosage Form

POWDER

Strength

1 g/g

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1114 View Details

Substance

CLOPROSTENOL SODIUM

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-01

End Marketing Date

Listing Record Certified Through

2026-12-31

2022

17 Aug

Drug for Further Processing NDC: 24584-1115

Nonproprietary Name

NALOXEGOL

Dosage Form

TABLET, FILM COATED

Strength

12.5 mg/1

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1115 View Details

Substance

NALOXEGOL OXALATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-08-17

End Marketing Date

Listing Record Certified Through

2026-12-31

2022

17 Aug

Drug for Further Processing NDC: 24584-1116

Nonproprietary Name

NALOXEGOL

Dosage Form

TABLET, FILM COATED

Strength

25 mg/1

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1116 View Details

Substance

NALOXEGOL OXALATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-08-17

End Marketing Date

Listing Record Certified Through

2026-12-31

2013

01 Jan

Drug for Further Processing NDC: 24584-1119

Nonproprietary Name

Spironolactone

Dosage Form

POWDER

Strength

25 kg/25kg

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1119 View Details

Substance

SPIRONOLACTONE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2013-01-01

End Marketing Date

Listing Record Certified Through

2026-12-31

2023

02 May

Drug for Further Processing NDC: 24584-1120

Nonproprietary Name

Bempedoic Acid

Dosage Form

TABLET, FILM COATED

Strength

180 mg/1

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1120 View Details

Substance

BEMPEDOIC ACID

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-05-02

End Marketing Date

Listing Record Certified Through

2026-12-31

2023

01 Feb

Drug for Further Processing NDC: 24584-1121

Nonproprietary Name

Ocaliva

Dosage Form

TABLET, FILM COATED

Strength

5 mg/1

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1121 View Details

Substance

OBETICHOLIC ACID

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-02-01

End Marketing Date

Listing Record Certified Through

2026-12-31

2023

01 Feb

Drug for Further Processing NDC: 24584-1122

Nonproprietary Name

Ocaliva

Dosage Form

TABLET, FILM COATED

Strength

10 mg/1

Labeler

Piramal Healthcare UK Limited

Marketing Category

DRUG FOR FURTHER PROCESSING

24584-1122 View Details

Substance

OBETICHOLIC ACID

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2023-02-01

End Marketing Date

Listing Record Certified Through

2026-12-31

Related Databases

FDA Inspections
7 View
EDQM CEP
0 View
KDMF
0 View
Japan DMF
2 View
Eudra GMP
0 View
NDC Database
10 View
FDA Approved Drugs Database
0 View
Drug Prices in Switzerland
0 View

NDC Type Breakdown

7 total

Drug for Further Processing

Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory

NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

24584-1114

Nonproprietary Name

Cloprostenol Sodium

Labeler

Piramal Healthcare UK Limited

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

Create a New Buying Request

Fields marked with * are mandatory.

Required Quantity *

Please enter quantity.

Measurement Unit *

Please select a unit.

Quality Standard *

Please select quality standard.

Request Type *

Please select request type.

Product Specifications *

Please provide product specifications.

Additional Details *

Please enter additional details.

Shipping Preference *

Please select shipping preference.

Expected Delivery Date

Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.